Citation Impact
Citing Papers
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
2005 Standout
Honokiol Induces a Necrotic Cell Death through the Mitochondrial Permeability Transition Pore
2007
Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression
2021 StandoutNobel
Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells
2017
Target-conditioned diffusion generates potent TNFR superfamily antagonists and agonists
2024 StandoutScienceNobel
Macrophages and cancer stem cells: a malevolent alliance
2021
Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins
2019
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Antibody-drug conjugates—an emerging class of cancer treatment
2016
Functional Roles of Calreticulin in Cancer Biology
2015
Photoactivatable CO release from engineered protein crystals to modulate NF-κB activation
2016 StandoutNobel
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Regulation of the Voltage Gated K<sup>+</sup> Channel K<sub>v1.3</sub> by Recombinant Human Klotho Protein
2014 Standout
An Acquired and Endogenous Glycocalyx Forms a Bidirectional “Don’t Eat” and “Don’t Eat Me” Barrier to Phagocytosis
2020 StandoutNobel
Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner
2012
Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
2021
Selective anticancer strategies via intervention of the death pathways relevant to cell transformation
2008
Phagocytosis checkpoints as new targets for cancer immunotherapy
2019
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
(-)-Epigallocatechin Gallate Regulates CD3-mediated T Cell Receptor Signaling in Leukemia through the Inhibition of ZAP-70 Kinase
2008
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Antibody-targeted drugs and drug resistance—Challenges and solutions
2014
The past and future of CD33 as therapeutic target in acute myeloid leukemia
2014
Therapeutic applications of compounds in the Magnolia family
2011 Standout
Thymoquinone: Potential cure for inflammatory disorders and cancer
2011 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Immunogenic cell death in cancer and infectious disease
2016 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Cancer stem cells revisited
2017 Standout
Antibody targeted drugs as cancer therapeutics
2006
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
2015 Standout
Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone
2015
Biological roles of glycans
2016 Standout
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
2010 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Styrene-maleic acid copolymer-encapsulated CORM2, a water-soluble carbon monoxide (CO) donor with a constant CO-releasing property, exhibits therapeutic potential for inflammatory bowel disease
2014
The generation, activation, and polarization of monocyte-derived macrophages in human malignancies
2023
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
2015
Nanovehicular Intracellular Delivery Systems
2008
TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme
2006
Pyroptosis: mechanisms and diseases
2021 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Caspase Functions in Cell Death and Disease
2013 Standout
Tim-3 Expression Defines Regulatory T Cells in Human Tumors
2013
RNAi-based therapeutic strategies for metabolic disease
2011
Modulation of Ocular Surface Glycocalyx Barrier Function by a Galectin-3 N-terminal Deletion Mutant and Membrane-Anchored Synthetic Glycopolymers
2013 StandoutNobel
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
2011 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Tissue-resident memory CD8+ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells
2019
High efficiency cell-specific targeting of cytokine activity
2014
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
Activation of apoptosis signalling pathways by reactive oxygen species
2016 Standout
TNF receptor agonists induce distinct receptor clusters to mediate differential agonistic activity
2021
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
TNF-related apoptosis-inducing ligand (TRAIL): A new path to anti-cancer therapies
2009
Molecular Genetic Pathways as Therapeutic Targets in Acute Myeloid Leukemia
2008
Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells
2020 StandoutNobel
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Effect of Carbon Monoxide Donor CORM-2 on Vitamin D<sub>3</sub> Metabolism
2013
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance
2009 Standout
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
The TRAIL apoptotic pathway in cancer onset, progression and therapy
2008
Apo2L/TRAIL and the Death Receptor 5 Agonist Antibody AMG 655 Cooperate to Promote Receptor Clustering and Antitumor Activity
2014
The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
2019 StandoutNobel
The cancer genome
2009 StandoutNature
Macrophages as tools and targets in cancer therapy
2022
Update on the Autoimmune Pathology of Multiple Sclerosis: B-Cells as Disease-Drivers and Therapeutic Targets
2015
Acute Myeloid Leukemia
2015 Standout
Extracellularly Activated Nanocarriers: A New Paradigm of Tumor Targeted Drug Delivery
2009
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Identification of novel molecular regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in breast cancer cells by RNAi screening
2014
Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy
2018
New insights into the role of EMT in tumor immune escape
2017
Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection
2012
Spermidine in health and disease
2018 StandoutScience
Glycobiology simplified: diverse roles of glycan recognition in inflammation
2016
Antibody therapy for acute myeloid leukaemia
2013
Enhancement of antitumor properties of TRAIL by targeted delivery to the tumor neovasculature
2008
Immunotoxins for leukemia
2014
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
The B-Side of Cancer Immunity: The Underrated Tune
2019
pH-Operated Nanopistons on the Surfaces of Mesoporous Silica Nanoparticles
2010 StandoutNobel
T Cell-Specific siRNA Delivery Using Antibody-Conjugated Chitosan Nanoparticles
2012
Procaspase-3 Activation as an Anti-Cancer Strategy: Structure−Activity Relationship of Procaspase-Activating Compound 1 (PAC-1) and Its Cellular Co-Localization with Caspase-3
2009
Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
Works of Edwin Bremer being referenced
Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial
2020
Simultaneous Inhibition of Epidermal Growth Factor Receptor (EGFR) Signaling and Enhanced Activation of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Receptor-mediated Apoptosis Induction by an scFv:sTRAIL Fusion Protein with Specificity for Human EGFR
2005
A novel AML-selective TRAIL fusion protein that is superior to Gemtuzumab Ozogamicin in terms of in vitro selectivity, activity and stability
2009
Antibody-Based Cancer Therapy
2017
The histone deacetylase inhibitor valproic acid potently augments gemtuzumab ozogamicin-induced apoptosis in acute myeloid leukemic cells
2006
The Ever-Expanding Immunomodulatory Role of Calreticulin in Cancer Immunity
2015
Exceptionally Potent Anti-Tumor Bystander Activity of an scFv:sTRAIL Fusion Protein with Specificity for EGP2 Toward Target Antigen-Negative Tumor Cells
2004
Target cell‐restricted and ‐enhanced apoptosis induction by a scFv:sTRAIL fusion protein with specificity for the pancarcinoma‐associated antigen EGP2
2003
Targeted induction of apoptosis for cancer therapy: current progress and prospects
2006
C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicity
2015
Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein
2007
Mechanisms of Translocation of ER Chaperones to the Cell Surface and Immunomodulatory Roles in Cancer and Autoimmunity
2015
Frequency of Th17 CD20+ cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjects
2011
Antibody-based fusion proteins to target death receptors in cancer
2011
Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis
2019
Potent Systemic Anticancer Activity of Adenovirally Expressed EGFR-Selective TRAIL Fusion Protein
2008
Targeted Cancer Immunotherapy Using Ligands of the Tumor Necrosis Factor Super-Family
2009
Carbon monoxide-Releasing Molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats
2010
Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo
2010
Target Cell–Restricted Apoptosis Induction of Acute Leukemic T Cells by a Recombinant Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Fusion Protein with Specificity for Human CD7
2005
Therapeutic potential of Galectin‐9 in human disease
2011
Targeting of the Tumor Necrosis Factor Receptor Superfamily for Cancer Immunotherapy
2013
CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy
2016
CD7-restricted activation of Fas-mediated apoptosis: a novel therapeutic approach for acute T-cell leukemia
2005
CD20-selective inhibition of CD47-SIRPα “don't eat me” signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumab
2017